Ultragenyx Pharmaceutical Inc. (RARE)
NASDAQ · Healthcare
Ultragenyx Pharmaceutical Inc. Net Income 2016–2025
Ultragenyx Pharmaceutical Inc. annual/quarterly net income history and growth rate from 2016 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Ultragenyx Pharmaceutical Inc. net income for the quarter ending March 31, 2026 was -185.0 M, a 22.52% increase year-over-year.
- Ultragenyx Pharmaceutical Inc. net income for the twelve months ending March 31, 2026 was -631.4 M, a 6.03% increase year-over-year.
- Ultragenyx Pharmaceutical Inc. annual net income for 2025 was -575.0 M, a 1.05% increase from 2024.
- Ultragenyx Pharmaceutical Inc. annual net income for 2024 was -569.0 M, a 6.26% decrease from 2023.
- Ultragenyx Pharmaceutical Inc. annual net income for 2023 was -607.0 M, a 14.20% decrease from 2022.
- Ultragenyx Pharmaceutical Inc. annual net income for 2022 was -707.4 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Ultragenyx Pharmaceutical Inc. Net Income — FAQ
Ultragenyx Pharmaceutical Inc. (RARE) net income over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
What is Ultragenyx Pharmaceutical Inc.'s net income?
Ultragenyx Pharmaceutical Inc. (RARE) reported net income of -$575M for fiscal 2025.
Where can I see RARE's net income history?
The chart and table above show Ultragenyx Pharmaceutical Inc.'s net income by year and by quarter, including the growth rate.